Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis.
Silvia MartiniMarco SaccoSilvia StronaDaniele AreseFrancesco TandoiDominic Dell OlioDavide StradellaDonatella CocchisStefano MirabellaGiorgia RizzaPaola MagistroniPamela MoschiniAntonio OttobrelliAntonio AmorosoMario RizzettoMauro SalizzoniGiorgio M SaraccoRenato RomagnoliPublished in: Liver international : official journal of the International Association for the Study of the Liver (2016)
At about 1 year from the completion of successful sofosbuvir-based therapy, patients with post-LT HCV and severe fibrosis experienced a long-term liver function improvement accompanied by a regression of fibrosis stage in half of them.